Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Andrew Tonkin, David Hunt, Merryn Voysey, Y Antero Kesaniemi, Andrew Hamer, Johnathon Waites, Leo Mahar, Stewart Mann, Paul Glasziou, Peta Forder, John Simes, Anthony Keech

Research output: Contribution to journalArticleResearchpeer-review

22 Citations (Scopus)


In the FIELD study, comparison of the effect of fenofibrate on cardiovascular disease (CVD) between those with prior CVD and without was a prespecified subgroup analysis.
Original languageEnglish
Pages (from-to)508 - 514
Number of pages7
JournalAmerican Heart Journal
Issue number3
Publication statusPublished - 2012

Cite this